Potentiation of slow component of delayed rectifier K(+) current by cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G

Br J Pharmacol. 2002 Sep;137(1):127-37. doi: 10.1038/sj.bjp.0704843.

Abstract

1. Regulation of the slowly activating component of delayed rectifier K(+) current (I(Ks)) by intracellular guanosine 3'5' cyclic monophosphate (cGMP) was investigated in guinea-pig sino-atrial (SA) node cells using the whole-cell patch-clamp method. 2. When a cell was dialyzed with pipette solution containing 100 micro M cGMP, I(Ks) started to gradually increase and reached a maximum increase of a factor of 2.37 +/- 0.39 (n = 4) about 10-15 min after rupture of patch membrane. Atrial natriuretic peptide (ANP, 100 nM) also potentiated I(Ks), consistent with intracellular cGMP-induced enhancement of I(Ks). 3. Bath application of a selective blocker of the cGMP-inhibited phosphodiesterase (PDE3) milrinone (100 microM) enhanced I(Ks) by a factor of 1.50 +/- 0.09 (n = 4) but failed to further enhance I(Ks) after a maximum stimulation by intracellular cGMP (100 microM), suggesting that blockade of PDE3 activity is involved in the enhancement of I(Ks). A potent but nonspecific PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX, 100 microM) further increased I(Ks) stimulated by 100 microM milrinone, indicating that PDE subtypes other than PDE3 are also involved in the regulation of basal I(Ks) in guinea-pig SA node cells. 4. Bath application of 100 microM 8-bromoguanosine 3'5' cyclic monophosphate (8-Br-cGMP) increased I(Ks) by a factor of 1.48 +/- 0.11 (n = 5) and this stimulatory effect was totally abolished by cGMP-dependent protein kinase (PKG) inhibitor KT-5823 (500 nM), suggesting that the activation of PKG also mediates cGMP-induced potentiation of I(Ks). 5. These results strongly suggest that intracellular cGMP potentiates I(Ks) not only by blocking PDE3 but also by activating PKG in guinea-pig SA node cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • 3',5'-Cyclic-AMP Phosphodiesterases / metabolism*
  • Animals
  • Atrial Natriuretic Factor / pharmacology
  • Atrial Natriuretic Factor / physiology
  • Cyclic GMP / analogs & derivatives*
  • Cyclic GMP / physiology*
  • Cyclic GMP-Dependent Protein Kinases / metabolism*
  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • Delayed Rectifier Potassium Channels
  • Enzyme Activation
  • Female
  • Guinea Pigs
  • In Vitro Techniques
  • Membrane Potentials
  • Patch-Clamp Techniques
  • Phosphodiesterase Inhibitors / pharmacology
  • Potassium Channels / physiology*
  • Potassium Channels, Voltage-Gated*
  • Sinoatrial Node / cytology
  • Sinoatrial Node / metabolism

Substances

  • Delayed Rectifier Potassium Channels
  • Phosphodiesterase Inhibitors
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • 8-bromocyclic GMP
  • Atrial Natriuretic Factor
  • Cyclic GMP-Dependent Protein Kinases
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • Cyclic GMP
  • 1-Methyl-3-isobutylxanthine